| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women.
|
JAMA
|
2004
|
3.17
|
|
2
|
The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report.
|
J Am Coll Cardiol
|
1999
|
2.79
|
|
3
|
Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.
|
J Am Coll Cardiol
|
2010
|
2.68
|
|
4
|
Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study.
|
Circulation
|
2004
|
2.67
|
|
5
|
Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
|
Circulation
|
2004
|
2.50
|
|
6
|
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
|
Circulation
|
2004
|
2.30
|
|
7
|
Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study.
|
Am Heart J
|
2001
|
2.22
|
|
8
|
Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory).
|
Am J Cardiol
|
2001
|
2.12
|
|
9
|
Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
|
Circulation
|
2004
|
2.12
|
|
10
|
Heterogeneity of microvascular dysfunction in women with chest pain not attributable to coronary artery disease: implications for clinical practice.
|
Am Heart J
|
2003
|
1.61
|
|
11
|
Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study.
|
J Am Coll Cardiol
|
1999
|
1.59
|
|
12
|
Determination of menopausal status in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study.
|
J Womens Health (Larchmt)
|
2004
|
1.57
|
|
13
|
Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study.
|
J Am Coll Cardiol
|
2003
|
1.44
|
|
14
|
Social networks are associated with lower mortality rates among women with suspected coronary disease: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation study.
|
Psychosom Med
|
2004
|
1.36
|
|
15
|
Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation.
|
Circulation
|
2004
|
1.28
|
|
16
|
Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study.
|
J Am Coll Cardiol
|
2004
|
1.21
|
|
17
|
Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
|
Am J Hum Genet
|
2002
|
1.10
|
|
18
|
Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease.
|
Circulation
|
2003
|
1.07
|
|
19
|
Physical activity and functional capacity measurement in women: a report from the NHLBI-sponsored WISE study.
|
J Womens Health Gend Based Med
|
2000
|
1.06
|
|
20
|
Large brachial artery diameter is associated with angiographic coronary artery disease in women.
|
Am Heart J
|
2002
|
1.06
|
|
21
|
Mild renal insufficiency is associated with angiographic coronary artery disease in women.
|
Circulation
|
2002
|
1.05
|
|
22
|
Global inflammation predicts cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study.
|
Am Heart J
|
2005
|
1.04
|
|
23
|
History of anxiety disorders is associated with a decreased likelihood of angiographic coronary artery disease in women with chest pain: the WISE study.
|
J Am Coll Cardiol
|
2001
|
0.99
|
|
24
|
Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory.
|
Am Heart J
|
2013
|
0.97
|
|
25
|
Renal function and coronary microvascular dysfunction in women with symptoms/signs of ischemia.
|
PLoS One
|
2015
|
0.96
|
|
26
|
Exercise treadmill testing using a modified exercise protocol in women with suspected myocardial ischemia: findings from the National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).
|
Am Heart J
|
2005
|
0.93
|
|
27
|
Hostility scores are associated with increased risk of cardiovascular events in women undergoing coronary angiography: a report from the NHLBI-Sponsored WISE Study.
|
Psychosom Med
|
2005
|
0.91
|
|
28
|
Association between beta-adrenergic receptor polymorphisms and their G-protein-coupled receptors with body mass index and obesity in women: a report from the NHLBI-sponsored WISE study.
|
Int J Obes (Lond)
|
2005
|
0.91
|
|
29
|
Weight cycling and high-density lipoprotein cholesterol in women: evidence of an adverse effect: a report from the NHLBI-sponsored WISE study. Women's Ischemia Syndrome Evaluation Study Group.
|
J Am Coll Cardiol
|
2000
|
0.89
|
|
30
|
Psychosocial variables are associated with atherosclerosis risk factors among women with chest pain: the WISE study.
|
Psychosom Med
|
2001
|
0.88
|
|
31
|
Socioeconomic status variables predict cardiovascular disease risk factors and prospective mortality risk among women with chest pain. The WISE Study.
|
Behav Modif
|
2003
|
0.86
|
|
32
|
Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
|
J Transl Med
|
2008
|
0.86
|
|
33
|
Electrocardiographic predictors of cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
|
J Am Coll Cardiol
|
2005
|
0.86
|
|
34
|
APOE polymorphism and angiographic coronary artery disease severity in the Women's Ischemia Syndrome Evaluation (WISE) study.
|
Atherosclerosis
|
2003
|
0.85
|
|
35
|
Validation of the accuracy of pretest and exercise test scores in women with a low prevalence of coronary disease: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
|
Am Heart J
|
2004
|
0.84
|
|
36
|
TIMI frame count and adverse events in women with no obstructive coronary disease: a pilot study from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
|
PLoS One
|
2014
|
0.83
|
|
37
|
Electrocardiogram abnormalities predict angiographic coronary artery disease in women with chest pain: results from the NHLBI WISE Study.
|
Clin Cardiol
|
2002
|
0.83
|
|
38
|
Effect of coronary angiography on use of lipid-lowering agents in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. For the WISE Investigators.
|
Am J Cardiol
|
2000
|
0.80
|
|
39
|
Diagnostic, prognostic, and cost assessment of coronary artery disease in women.
|
Am J Manag Care
|
2001
|
0.80
|
|
40
|
Hormone replacement, race, and psychological health in women: a report from the NHLBI-Sponsored WISE Study.
|
J Womens Health (Larchmt)
|
2004
|
0.80
|
|
41
|
Large-scale gene-centric analysis identifies polymorphisms for resistant hypertension.
|
J Am Heart Assoc
|
2014
|
0.79
|
|
42
|
Mild renal dysfunction and long-term adverse outcomes in women with chest pain: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).
|
Am Heart J
|
2015
|
0.78
|
|
43
|
Dobutamine stress echocardiography in women with chest pain. Pilot phase data from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE).
|
J Am Coll Cardiol
|
1999
|
0.76
|
|
44
|
Cholesterol-lowering medication, cholesterol level, and reproductive hormones in women: the Women's Ischemia Syndrome Evaluation (WISE).
|
Am J Med
|
2002
|
0.75
|
|
45
|
Number and function of bone-marrow derived angiogenic cells and coronary flow reserve in women without obstructive coronary artery disease: a substudy of the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
|
PLoS One
|
2013
|
0.75
|
|
46
|
Estrogens, progestins, selective estrogen receptor modulators, and the arterial tree.
|
Am J Obstet Gynecol
|
2001
|
0.75
|
|
47
|
Cardiac magnetic resonance imaging for myocardial perfusion and diastolic function-reference control values for women.
|
Cardiovasc Diagn Ther
|
2016
|
0.75
|